Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
An RCT including 85 women with different indications for ICSI who have been supplemented with AOX daily from the cycle preceding ICSI cycle, versus 85 women who were not given any AOX acting as controls, concluded that AOX therapy did not change clinical or laboratory outcomes (225)
in rats with abdominal aorta anastomosis BPC 157 both prevents thrombotic clot formation and destroys already formed thrombosis (40) and also, after amputation, BPC 157 reduces bleeding time and thrombocytopenia after heparin, warfarin or aspirin administration (41)
Pure Encapsulations takes a slightly different approach than the other products in this guide by pairing NAC with glycine, an amino acid found naturally in protein-rich foods
BPC-157 is not registered as a drug in any jurisdiction, and its clinical development (PL 14736, Diagen) halted at phase II and was abandoned in 2014
